Items tagged with Advocacy
Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB (post with simple image)
Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.
MSF: Johnson & Johnson should make TB drug available for all at $1/day (post with simple image)
MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.
Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients (post with simple image)
Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.
Call to action: Pledge your support for the Global Fund (post with simple image)
Sign the petition to urge governments to fully replenish the Global Fund!
It’s Time to End Drug-Resistant Tuberculosis: The Case for Action (post with simple image)
The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.
Research, regulatory, and access considerations regarding pretomanid (post with simple image)
TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on the TB Alliance's new drug application for pretomanid.
Community capacity building modules to accelerate DR-TB response (post with simple image)
Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.
Declaration of the Rights of People Affected by TB launched (post with simple image)
The launch of the Declaration is a significant step in recognizing the urgent need to adopt a human rights-based approach to TB and fund human rights-based interventions that overcome barriers to universal access.
Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB (post with simple image)
Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.
FDA Antimicrobial Drugs Advisory Committee recommends approval of pretomanid (post with simple image)
Investigational drug pretomanid is under regulatory review by FDA for treatment of XDR-TB and treatment-intolerant or non-responsive MDR-TB as part of a new investigational regimen.
Page 82 of 88 · Total posts: 0←First 81 82 83 Last→